Literature DB >> 14512367

Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease.

Alex E Roher1, Chera Esh, Tyler A Kokjohn, Walter Kalback, Dean C Luehrs, James D Seward, Lucia I Sue, Thomas G Beach.   

Abstract

OBJECTIVE: We conducted a quantitative investigation of brain arterial atherosclerotic damage and its relationship to sporadic Alzheimer's disease (AD). METHODS AND
RESULTS: Fifty-four consecutive autopsy cases, 32 AD and 22 nondemented control subjects, were examined to establish the degree of arterial stenosis. Vessel external and lumenal area measurements were taken from 3-mm arterial cross-sections to calculate a stenosis index. AD patient circle of Willis arteries possessed a significant degree of stenosis as a consequence of multiple and severe atherosclerotic lesions. These lesions were significantly more severe in AD cases than in age-matched controls (P<0.0001), and the number of stenoses and the index of occlusion (R=0.67; P<0.00001) were positively correlated. In addition, the index of stenosis significantly correlated with the following measures of AD neuropathological lesions: total plaque score, neuritic plaque score, neurofibrillary tangle score, Braak stage score, and white matter rarefaction score.
CONCLUSIONS: Our study reveals an association between severe circle of Willis atherosclerosis and sporadic AD that should be considered a risk factor for this dementia. These observations strongly suggest that atherosclerosis-induced brain hypoperfusion contributes to the clinical and pathological manifestations of AD.

Entities:  

Mesh:

Year:  2003        PMID: 14512367     DOI: 10.1161/01.ATV.0000095973.42032.44

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  103 in total

Review 1.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Coronary risk correlates with cerebral amyloid deposition.

Authors:  Bruce R Reed; Natalie L Marchant; William J Jagust; Charles C DeCarli; Wendy Mack; Helena C Chui
Journal:  Neurobiol Aging       Date:  2011-11-10       Impact factor: 4.673

3.  Cerebrovascular lesions induce transient β-amyloid deposition.

Authors:  Monica Garcia-Alloza; Julia Gregory; Kishore V Kuchibhotla; Sara Fine; Ying Wei; Cenk Ayata; Matthew P Frosch; Steven M Greenberg; Brian J Bacskai
Journal:  Brain       Date:  2011-11-26       Impact factor: 13.501

4.  Determinants of vascular dementia in the Cardiovascular Health Cognition Study.

Authors:  L H Kuller; O L Lopez; W J Jagust; J T Becker; S T DeKosky; C Lyketsos; C Kawas; J C S Breitner; A Fitzpatrick; C Dulberg
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910

5.  Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization.

Authors:  Hyung Jin Ahn; Daria Zamolodchikov; Marta Cortes-Canteli; Erin H Norris; J Fraser Glickman; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 6.  Hypertension and cerebrovascular dysfunction.

Authors:  Costantino Iadecola; Robin L Davisson
Journal:  Cell Metab       Date:  2008-06       Impact factor: 27.287

Review 7.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 8.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

9.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

Review 10.  Linking vascular disorders and Alzheimer's disease: potential involvement of BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Neurobiol Aging       Date:  2008-03-04       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.